This T32 training program, which is closely associated with the University of Minnesota adult Infectious Diseases fellowship program, is designed to prepare MD, MD/PhD, and other post- doctoral trainees for successful careers as clinical, epidemiological, and translational investigators in Infectious Diseases, with a focus on emerging / reemerging infections and global health. The program has 5 post-doctoral slots per year and accepts 2 new trainees annually, usually following an initial year of clinical Infectious Diseases training. Trainees undergo a 2-to-3 year intensive research experience, either locally or at an affiliated international site, supervised by one of 28 expert faculty mentors who represent diverse disciplines and departments within the Medical School, School of Public Health, College of Pharmacy, and College of Veterinary Medicine. Trainees participate in didactics (including in Responsible Conduct of Research, biostatistics, and grant-writing), a journal club, and a research conference series, plus local, regional, and national Infectious Diseases meetings. Trainees can obtain an MS-Clinical Research degree or an MPH in Epidemiology, can take individual courses within the School of Public Health, and can take a Global Health course that qualifies them to sit for the Certificate examination in Tropical Medicine and Hygiene. Oversight of trainee progress is by the Program Director and a Scholarship Oversight Committee, which meets semiannually with each trainee. Trainee selection and program governance are by the Program Director and a Steering/Selection Committee. Continuous program improvement is guided by feedback from current and former trainees, the Scholarship Oversight Committee, and an External Advisory Committee. Multiple program graduates now sustain successful research-intensive careers at the University of Minnesota and other institutions.

Public Health Relevance

This T32 training program is designed to train new clinical, epidemiological, and translational infectious disease investigators, who are needed to discover better ways to diagnose, treat, and prevent serious emerging and re-emerging infections and other Global Health threats such as malaria, HIV/AIDS, influenza, C. difficile, and antimicrobial-resistant infections. The program draws on multiple schools and colleges within the University of Minnesota, plus a Global Health course and several international sites, to provide post-doctoral trainees - primarily Infectious Disease physicians - with the advanced skills needed for a successful career in infectious diseases research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI055433-12
Application #
9088279
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Robbins, Christiane M
Project Start
2003-09-01
Project End
2020-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
12
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Kajumbula, Henry; Fujita, Ayako Wendy; Mbabazi, Olive et al. (2018) Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda. Emerg Infect Dis 24:174-175
Yared, Nicholas; Horvath, Keith; Fashanu, Oluwaseun et al. (2018) Optimizing Screening for Sexually Transmitted Infections in Men Using Self-Collected Swabs: A Systematic Review. Sex Transm Dis 45:294-300
Mpoza, Edward; Mukaremera, Liliane; Kundura, Didas Atwebembere et al. (2018) Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection. PLoS One 13:e0190652
Mpoza, Edward; Rhein, Joshua; Abassi, Mahsa (2018) Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis. Med Mycol Case Rep 19:30-32
Johnson, James R (2018) Confusion and Bacteriuria in Long-Term Care Facility Residents. J Am Geriatr Soc 66:1235
Bahr, Nathan C; Panackal, Anil A; Durkin, Michelle M et al. (2018) Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies. Mycoses :
Diehl, John W; Hullsiek, Katherine H; Okirwoth, Michael et al. (2018) Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis. Open Forum Infect Dis 5:ofy105
Pragman, Alexa A; Lyu, Tianmeng; Baller, Joshua A et al. (2018) The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome 6:7
Bahr, Nathan C; Nuwagira, Edwin; Evans, Emily E et al. (2018) Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 18:68-75
Bahr, Nathan C; Halupnick, Ryan; Linder, Grace et al. (2018) Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. Biomark Med 12:707-716

Showing the most recent 10 out of 85 publications